Levetiracetam Tablet
Product Images NDC 43063-499

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 43063-499). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063499 Label (43063499)

This is a description of a medication containing LevETIRAcetam USP 500mg in tablet form. There are three bottles with 60 tablets each, and they have the same ReOrder and LOT numbers. The expiration date is 09/2021. The tablets are yellow, oval/brelined, with the marking 1015 500mg. The package insert provides only Dosage and Storage information, and there is a warning to keep away from children. The instructions indicate to take the tablet(s) 'times a day'. The text includes a phone number to call the doctor for medical advice about side effects, and to report side effects to the FDA. The last line is not readable.*

FDA Label Image

Ectdmodule1usa1

FDA Label Image

Ectdmodule1usa2

FDA Label Image

Ectdmodule1usa3

This is a chart depicting the percentage of patients in a study who were given a placebo or varying doses of levetiracetam, a medication commonly used to treat epilepsy. The percentages represent the proportion of patients in each group, with 35.2% receiving a placebo, 20.8% receiving 1000mg/day of levetiracetam, and 6.3% receiving 2000mg/day of levetiracetam. The study included 111 patients in the placebo group, and 106 and 105 patients in the two levetiracetam dosage groups, respectively.*

FDA Label Image

Ectdmodule1usa4

FDA Label Image

Ectdmodule1usa5

This appears to be a table showing percentages of patients in a study related to the medication Levetiracetam compared to a placebo group. It is unclear what the percentages represent as there are no column or row labels. The text also includes special characters such as "%" and "@", which may suggest that the original document was not properly converted to text via .*

FDA Label Image

Ectdmodule1usa6

FDA Label Image

Ectdmodule1usa7

The text "45.2%" appears to be a statistic and does not provide enough information to generate a useful description. The rest of the text refers to a study with a placebo group and a group taking levetiracetam, a medication commonly used to treat seizures. However, without more context or information about the study, a description cannot be provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.